Ajanta Pharma Buyback 2023 vs Symphony Buyback

Comparison between Ajanta Pharma Buyback 2023 and Symphony Buyback.

Buyback Details

Ajanta Pharma Buyback 2023 is a Tender Offer buyback proposed to list at BSE, NSE while Symphony Buyback is a Tender Offer proposed to list at BSE, NSE.

 Ajanta Pharma Ltd.Symphony Ltd.
LogoAjanta Pharma Buyback 2023 LogoSymphony Buyback Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE, NSE
Face Value₹2 per share₹2 per share
Buyback Price₹1425 per share₹2000 per share
Issue Size22,10,500 shares10,00,000 shares
Issue Size (Amount)₹315.00 Crores₹200.00 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders20 Equity Shares out of every 99 Fully paid-up Equity Shares held on the Record Date.331,575.00
General Category for all other Eligible Shareholders3 Equity Shares out of every 202 Fully paid-up Equity Shares held on the Record Date.1,878,925.00
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders9 Equity Shares out of every 92 Fully paid-up Equity Shares held on the Record Date.150,000.00
General Category for all other Eligible Shareholders1 Equity Shares out of every 80 Fully paid-up Equity Shares held on the Record Date.850,000.00
RegistrarMUFG Intime India Pvt.Ltd.Bigshare Services Pvt.Ltd.
Lead ManagersEdelweiss Financial Services Ltd.Ambit Pvt.Ltd.
Necessity of the buyback

The buyback is being undertaken for the following reasons:

  1. The buyback will help the company to return surplus cash to its equity shareholders broadly in proportion to their shareholding, thereby enhancing the overall return to shareholders.
  2. The buyback consists of a reservation for the small shareholder. The company believes that this reservation for small shareholders would benefit a large number of public shareholders who would get classified as "small shareholders".
  3. The buyback may help in improving return on equity, reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.
  5. The buyback may lead to a reduction in outstanding Equity Shares, an improvement in earnings per equity share, and an enhanced return on equity.

The Buyback is being undertaken for the following reasons:

  1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares.
  2. The buyback consists of a reservation for the small shareholder. The company believes that this reservation for small shareholders would benefit a large number of public shareholders who would get classified as "small shareholders".
  3. The buyback may help in improving return on equity, reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.

Buyback Timetable

Ajanta Pharma Buyback 2023 and Symphony Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Ajanta Pharma Buyback 2023 Buyback record date is Mar 24, 2023. Symphony Buyback Buyback record date is Mar 29, 2023.

 Ajanta Pharma Ltd.Symphony Ltd.
Record DateMar 24, 2023Mar 29, 2023
Offer Open DateMar 31, 2023May 03, 2023
Offer Closure DateApr 10, 2023May 17, 2023
Last date for receipt of tender formsApr 10, 2023May 17, 2023
Finalisation of buybackApr 13, 2023May 25, 2023
Last Date for settlment of bidsApr 18, 2023May 26, 2023
Last Date for extinguishment of sharesApr 27, 2023Jun 02, 2023

Financial Details and Other Relevent Information

Comparison of Ajanta Pharma Buyback 2023 and Symphony Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Ajanta Pharma Ltd.Symphony Ltd.
Financial
Ajanta Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-202,680.06467.70
31-Mar-213,778.722,915.67653.87
31-Mar-224,055.583,456.67712.68
Amount in ₹ Crore
Symphony Limited Financial Information (Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-201,064.001,157.00182.00
31-Mar-211,220.00931.00107.00
31-Mar-221,367.001,079.00121.00
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1252.00 4523.00 1197.49
Jan-2023 1222.90 3168.00 1186.12
Dec-2022 1272.00 1192.00 1210.90

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1174.85 948.00 1051.97
Jan-2023 1004.95 900.05 959.76
Dec-2022 950.35 870.00 914.00
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1254.00 1151.35 1198.12
Jan-2023 1224.00 1150.00 1186.49
Dec-2022 1266.25 1150.25 1210.19

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1175.00 948.00 1051.93
Jan-2023 1006.00 907.20 960.03
Dec-2022 949.00 870.00 914.21

Compare with others

Compare:

Ajanta Pharma Buyback 2023 and Symphony Buyback